Glycogen storage disease type I

From WikiMD's Medical Encyclopedia

(Redirected from Von Gierke disease)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Glycogen storage disease type I
Synonyms Von Gierke disease, GSD I
Pronounce
Specialty Endocrinology, Genetics
Symptoms Hypoglycemia, lactic acidosis, hyperuricemia, hyperlipidemia
Complications N/A
Onset Infancy
Duration Lifelong
Types Type Ia, Type Ib
Causes Genetic mutations in G6PC or SLC37A4
Risks
Diagnosis Genetic testing, liver biopsy
Differential diagnosis Other glycogen storage diseases, Fructose-1,6-bisphosphatase deficiency
Prevention
Treatment Dietary management, cornstarch therapy, allopurinol, liver transplantation
Medication
Prognosis Variable, dependent on management
Frequency 1 in 100,000 births
Deaths N/A


Glycogen storage disease type I (GSD I) is a inherited disease. In this disorder, the liver being unable to properly break down stored glycogen.

Alternate names[edit]

GSD1; Glycogen storage disease 1A; Von Gierke disease; Glycogenosis type 1; Hepatorenal form of glycogen storage disease; Glucose-6-phosphatase deficiency; Hepatorenal glycogenosis; Glucose-6-phosphatase deficiency glycogen storage disease See Less

Clinical features[edit]

Glycogen storage disease type 1 is an inherited disorder caused by the buildup of a complex sugar called glycogen in the body's cells. The accumulation of glycogen in certain organs and tissues, especially the liver, kidneys, and small intestines, impairs their ability to function normally.

Types[edit]

These types are known as glycogen storage disease type IA and glycogen storage disease type IB.

Cause[edit]

Glycogen storage disease type 1A is caused by the deficiency of glucose-6-phosphatase (G6Pase) catalytic activity which results from mutations in the G6PC gene.

Inheritance[edit]

This condition is inherited in an autosomal recessive pattern.

Characteristics[edit]

Glycogen storage disease type 1A is characterized by growth retardation leading to short stature and accumulation of glycogen and fat in the liver and kidneys. Although some newborns present with severe hypoglycemia, it is more common for infants to present at age three to four months with hepatomegaly, lactic acidosis, hyperuricemia, hyperlipidemia, and/or hypoglycemic seizures.

Symptoms[edit]

80%-99% of people have these symptoms

5%-29% of people have these symptoms

Less common symptoms[edit]

Autosomal recessive
Autosomal recessive

Diagnosis[edit]

  • Making a diagnosis for a genetic or rare disease can often be challenging.
  • Healthcare professionals typically look at a person‚Äôs medical history, symptoms, physical exam, and laboratory test results in order to make a diagnosis.

Genetic Testing Resources[edit]

The Genetic Testing Registry (GTR) provides information about the genetic tests for this condition

Treatment[edit]

Treatment is supportive care as there is no cure.

Complications / course[edit]

  • Untreated children typically have doll-like faces with fat cheeks and relatively thin extremities.
  • Xanthoma and diarrhea may be present.
  • Impaired platelet function can lead to a bleeding tendency, making epistaxis a frequent problem.
UpToDate

Latest articles - Glycogen storage disease type I

PubMed
Clinical trials

Glycogen storage disease type I on Wikipedia[edit]

Wikipedia




NIH genetic and rare disease info[edit]

Glycogen storage disease type I is a rare disease.


This article is a stub.

You can help WikiMD by registering to expand it.
Editing is available only to registered and verified users.
WikiMD is a comprehensive, free health & wellness encyclopedia.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.